CVE:GSD Devonian Health Group (GSD) Stock Price, News & Analysis C$0.12 -0.01 (-3.85%) (As of 11/19/2024 05:34 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChart About Devonian Health Group Stock (CVE:GSD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Devonian Health Group alerts:Sign Up Key Stats Today's RangeC$0.13▼C$0.1350-Day RangeC$0.11▼C$0.1652-Week RangeC$0.08▼C$0.35Volume7,500 shsAverage Volume19,924 shsMarket CapitalizationC$18.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDevonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.Read More… Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Receive GSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address GSD Stock News HeadlinesDevonian Appoints André P. Boulet to Chairman of the Board and Chief Operating OfficerJune 3, 2024 | financialpost.comDevonian Health Group Inc. to Participate in Three Renmark’s Virtual Non-Deal Roadshow SeriesOctober 24, 2022 | finance.yahoo.comBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. November 21, 2024 | WealthPress (Ad)Devonian Announces Executive Changes, Grant of Stock Options and Settlement of Interests and Repayment of Principal Amount Owed to a Debenture HolderAugust 29, 2022 | finance.yahoo.comDevonian Health Group Inc.May 28, 2022 | wsj.comJack Ma’s Ant Ekes Out Profit Rise as Fintech Overhaul AdvancesMay 27, 2022 | nz.finance.yahoo.comImplantable Biomaterials Global Market Report 2022May 27, 2022 | yahoo.comRussia avoids default at the last moment as a clearinghouse processes its dollar bond paymentsMay 6, 2022 | news.yahoo.comSee More Headlines GSD Stock Analysis - Frequently Asked Questions How have GSD shares performed this year? Devonian Health Group's stock was trading at C$0.15 at the beginning of 2024. Since then, GSD stock has decreased by 13.8% and is now trading at C$0.13. View the best growth stocks for 2024 here. How do I buy shares of Devonian Health Group? Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryComputer Software Current SymbolCVE:GSD CUSIPN/A CIKN/A Webwww.groupedevonian.com Phone450-937-6696FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-3,170,000.00 Net Margins-32.50% Pretax MarginN/A Return on Equity-23.31% Return on Assets-8.12% Debt Debt-to-Equity Ratio16.36 Current Ratio1.07 Quick Ratio7.82 Sales & Book Value Annual SalesC$9.75 million Price / Sales1.90 Cash FlowC$0.02 per share Price / Cash Flow6.10 Book ValueC$0.09 per share Price / Book1.39Miscellaneous Outstanding Shares148,220,000Free FloatN/AMarket CapC$18.53 million OptionableNot Optionable Beta1.28 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (CVE:GSD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Devonian Health Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Devonian Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.